drugset / Trial / NCT01378520

Effect of Ketoconazole on Breathlessness

NCT01378520

Phase 4 Completed 20 enrolled Dartmouth-Hitchcock Medical Center
RandomizedCrossoverQuadruple-blindTreatment

Summary

Beta-endorphins, which are naturally occurring narcotic substances, have been shown to alter the perception of breathlessness. Oral ketoconazole, an antifungal antibiotic, increases blood levels of beta-endorphins. The study hypothesis is that oral ketoconazole will reduce ratings of breathlessness induced by resistive breathing loads.

Timeline

Start
2011-06
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoconazole Small molecule 600 mg Oral